| NCT ID | NCT06830174 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Laryngeal Dystonia |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-04-14 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-04-14 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will apply transcranial direct current stimulation (tDCS) to multiple brain areas to evaluate the effects as a potential treatment for laryngeal dystonia (formerly spasmodic dysphonia).
Eligibility Criteria
Inclusion Criteria: * Participants must be clinically evaluated for the diagnosis of LD or have the proof of LD diagnosis. (Not applicable for control participants) * No other known or history of speech, voice disorder other than LD. * Provision of signed and dated informed consent form. * Stated willingness to comply with all study procedures and availability for the duration of the study * Must not be pregnant. Exclusion Criteria: * All individuals who do not meet the above mentioned criteria are excluded from the study. * Subjects with a history of epilepsy or depression or is claustrophobic.
Contact & Investigator
Nabin Koirala, PhD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT06830174 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Laryngeal Dystonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06830174 currently recruiting?
Yes, NCT06830174 is actively recruiting participants. Contact the research team at nabin.koirala@yale.edu for enrollment information.
Where is the NCT06830174 trial being conducted?
This trial is being conducted at New Haven, United States.
Who is sponsoring the NCT06830174 clinical trial?
NCT06830174 is sponsored by Yale University. The principal investigator is Nabin Koirala, PhD at Yale University. The trial plans to enroll 10 participants.